FDA Approved: MAVENCLAD — Original Application (EMD Serono, Inc.)

View source ↗

Summary

The FDA approved MAVENCLAD (cladribine) under its original application for the treatment of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• MAVENCLAD (cladribine)

Snippet

ORIG AP for MAVENCLAD (CLADRIBINE)